|
Platelet function inhibitors
Citations 71-80 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Coronary Heart Disease
Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance
- Andrew L. Frelinger, III, Mark I. Furman, Matthew D. Linden, Youfu Li, Marsha L. Fox, Marc R. Barnard, and Alan D. Michelson
Circulation 2006;113:2888-2896; published online before print as doi:10.1161/CIRCULATIONAHA.105.596627
[Abstract]
[Full text]
- Articles
Residual Arachidonic Acid-Induced Platelet Activation via an Adenosine Diphosphate-Dependent but Cyclooxygenase-1- and Cyclooxygenase-2-Independent Pathway. A 700-Patient Study of Aspirin Resistance
- Andrew L. Frelinger, III, Mark I. Furman, Matthew D. Linden, Youfu Li, Marsha L. Fox, Marc R. Barnard, and Alan D. Michelson
Circulation published June 19, 2006, doi:10.1161/CIRCULATIONAHA.105.596627
[Abstract]
- Editorials
Is Clopidogrel Cardiovascular Medicine’s Double-Edged Sword?
- Anthony A. Bavry and A. Michael Lincoff
Circulation 2006;113:1638-1640, doi:10.1161/CIRCULATIONAHA.105.617175
[Full text]
- Cardiovascular Surgery
Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?
- Emmanouil I. Kapetanakis, Diego A. Medlam, Kathleen R. Petro, Elizabeth Haile, Peter C. Hill, Mercedes K.C. Dullum, Ammar S. Bafi, Steven W. Boyce, and Paul J. Corso
Circulation 2006;113:1667-1674; published online before print as doi:10.1161/CIRCULATIONAHA.105.571828
[Abstract]
[Full text]
- Articles
Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery. Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?
- Emmanouil I. Kapetanakis, Diego A. Medlam, Kathleen R. Petro, Elizabeth Haile, Peter C. Hill, Mercedes K.C. Dullum, Ammar S. Bafi, Steven W. Boyce, and Paul J. Corso
Circulation published March 27, 2006, doi:10.1161/CIRCULATIONAHA.105.571828
[Abstract]
- Vascular Medicine
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation 2006;113:1244-1254; published online before print as doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
[Full text]
- Articles
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation published February 27, 2006, doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
- Correspondence
Letter Regarding Article by Markus et al, "Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Cardiac Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reducton of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial" • Response
- Christopher H.E. Imray, Daniel J. Higman, Colette Marshall, Stanley N. Cohen, Hugh S. Markus, Dirk W. Droste, Dirk W. Droste, E. Bernd Ringelstein, Manfred Kaps, Vincent Larrue, Kennedy R. Lees, and Mario Siebler
Circulation 2005;112:e325-326e, doi:10.1161/CIRCULATION.AHA.105.560755
[Full text]
- Interventional Cardiology
Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
- Nicolas von Beckerath, Dirk Taubert, Gisela Pogatsa-Murray, Edgar Schömig, Adnan Kastrati, and Albert Schömig
Circulation 2005;112:2946-2950; published online before print as doi:10.1161/CIRCULATIONAHA.105.559088
[Abstract]
[Full text]
- Correspondence
Letter Regarding Article by Valgimigli et al, "Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease" • Response
- Sacha Bull, Navtej Chahal, Charles J. McKenna, Marco Valgimigli, Carlos A.G. van Mieghem, Andrew T.L. Ong, Jiro Aoki, Gaston A. Rodriguez Granillo, Eugene P. McFadden, Pim J. De Feyter, Pieter C. Smits, Evelyn Regar, Willem J. Van der Giessen, George Sianos, Peter de Jaegere, Ron T. Van Domburg, Patrick W. Serruys, and Arie Pieter Kappetein
Circulation 2005;112:e306, doi:10.1161/CIRCULATIONAHA.105.564765
[Full text]
|
|
